-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Cardiology
- Clinics
- Consumer Products
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Neurology
- OBGYN
- Oncology
- Ophthalmology
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Psychiatry
- Radiology
- Rheumatology
- Risk Manager
- Uncategorized
Category Archives: Eye Care
FDA Warning Brilliant Blue G
Certain Compounded Drugs from Franck’s: FDA Issues Second Warning to Physicians Brilliant Blue G (BBG) Triamcinolone AUDIENCE: Eye Care, Family Practice, Pharmacy ISSUE: FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue … Continue reading
Posted in Eye Care, Family Practice, FDA 2012, FDA Warning, Pharmacy
Tagged Brilliant Blue G, Eye Care, eye infections, Family Practice, FDA warning, fungal endophthalmitis, Pharmacy, Triamcinolone
Comments Off
CooperVision Avaira Aquaform Sphere Soft Contact Lenses Class 1 Recall
CooperVision Avaira Aquaform Sphere Soft Contact Lenses: Class 1 Recall – Unintended Residue on Lenses AUDIENCE: Eye Care, Consumer ISSUE: The unintended presence of a silicone oil residue on lenses from certain lots of Avaira Aquaform Sphere contact lenses. Symptoms … Continue reading